BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2678522)

  • 1. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of the effectiveness of lasolvan and mucodine in chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Sov Med; 1988; (5):69-72. PubMed ID: 3062806
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of lasolvan on mucociliary transport in patients with chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Klin Med (Mosk); 1988 Mar; 66(3):45-7. PubMed ID: 3392922
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of lasolvan on the rheologic properties of sputum].
    Chuchalin AG; Solopov VN; Kolganova NA; Plisko LF
    Klin Med (Mosk); 1987 Mar; 65(3):52-4. PubMed ID: 3298838
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
    Dorow P; Weiss T
    Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.
    Ericsson CH; Juhász J; Mossberg B; Philipson K; Svartengren M; Camner P
    Eur J Respir Dis; 1987 Mar; 70(3):163-70. PubMed ID: 3569448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study on Lasolvan in chronic obstructive pulmonary disease.
    Král B; Ellás J; Rozánek P; Jirkal J; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(5):601-6. PubMed ID: 7051260
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease].
    Dorow P; Weiss T; Felix R; Schmutzler H
    Arzneimittelforschung; 1987 Dec; 37(12):1378-81. PubMed ID: 3449066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)].
    Curti PC; Renovanz HD
    Arzneimittelforschung; 1978; 28(5a):922-5. PubMed ID: 581991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New concepts in the therapy of mucostasis].
    von Seefeld H; Weiss JM; Rensch H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():896-900. PubMed ID: 6689074
    [No Abstract]   [Full Text] [Related]  

  • 12. Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function.
    Ericsson CH; Juhász J; Jönsson E; Mossberg B
    Eur J Respir Dis; 1986 Oct; 69(4):248-55. PubMed ID: 3545883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
    Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
    Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
    Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
    Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incorporation of a stimulant of synthesis and secretion of a pulmonary surfactant (ambroxol) into the treatment of otitis serosa].
    Bautista Calero del Castillo J; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    Acta Otorrinolaringol Esp; 1988; 39(1):61-4. PubMed ID: 3272269
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled trial of ambroxol in chronic bronchitis.
    Guyatt GH; Townsend M; Kazim F; Newhouse MT
    Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the fibre system and viscosity of the sputum of bronchitis during treatment with bromhexine and guaiphenesin (guaiacol glyceryl ether).
    Bürgi H
    Scand J Respir Dis Suppl; 1974; 90():81-5. PubMed ID: 4618378
    [No Abstract]   [Full Text] [Related]  

  • 19. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
    Romanini BM; Sandri MG; Tosi M; Mezzetti M; Mazzetti A
    Int J Clin Pharmacol Res; 1986; 6(2):123-7. PubMed ID: 3522443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucociliary clearance in early simple chronic bronchitis.
    Dirksen H; Hermansen F; Groth S; Mølgaard F
    Eur J Respir Dis Suppl; 1987; 153():145-9. PubMed ID: 3322859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.